These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 18942396)

  • 1. [Use of 18F-FDG PET scan in the diagnosis of large liver neoplasms and in the evaluation of therapeutic effectiveness].
    Balabanova AA; Tiutin LA; Kostenikov NA; Tlostanova MS; Ryzskova DV; Prozorovskiĭ KV
    Vopr Onkol; 2008; 54(4):434-8. PubMed ID: 18942396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications and advances of positron emission tomography with fluorine-18-fluorodeoxyglucose (18F-FDG) in the diagnosis of liver neoplasms.
    He YX; Guo QY
    Postgrad Med J; 2008 May; 84(991):246-51. PubMed ID: 18508981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant tumor with false negative 18F-FDG PET image].
    Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current possibilities of radiodiagnosis in liver tumors].
    Granov AM; Tiutin LA; Rozengauz EV; Prozorovskiĭ KV; Kalashnikov PA; Berezin SM; Iakovleva EK; Pozdniakov AV; Shelkoplias EN; Tlostanova MS; Ryzskova DV; Balabanova AA; Stanzhevskiĭ AA
    Vopr Onkol; 2008; 54(4):410-6. PubMed ID: 18942394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
    Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH
    Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy.
    Carnaghi C; Tronconi MC; Rimassa L; Tondulli L; Zuradelli M; Rodari M; Doci R; Luttmann F; Torzilli G; Rubello D; Al-Nahhas A; Santoro A; Chiti A
    Nucl Med Rev Cent East Eur; 2007; 10(1):12-5. PubMed ID: 17694495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings.
    Lubezky N; Metser U; Geva R; Nakache R; Shmueli E; Klausner JM; Even-Sapir E; Figer A; Ben-Haim M
    J Gastrointest Surg; 2007 Apr; 11(4):472-8. PubMed ID: 17436132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response assessment of colorectal liver metastases with contrast enhanced CT/18F-FDG PET.
    García Vicente AM; Domínguez Ferreras E; Sánchez Pérez V; Poblete García VM; Villa Guzmán JC; Jiménez Aragón F; Pineda Pineda MD; Molino Trinidad C; Soriano Castrejón Á
    Eur J Radiol; 2013 Jun; 82(6):e255-61. PubMed ID: 23414715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases.
    Truant S; Huglo D; Hebbar M; Ernst O; Steinling M; Pruvot FR
    Br J Surg; 2005 Mar; 92(3):362-9. PubMed ID: 15672427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F]Fluorodeoxyglucose positron emission tomography surveillance of hepatic metastases from prostate cancer following radiofrequency ablation: a case report.
    Ludwig V; Hopper OW; Martin WH; Kikkawa R; Delbeke D
    Am Surg; 2003 Jul; 69(7):593-8. PubMed ID: 12889623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
    Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
    Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapy.
    Kong BY; Menzies AM; Saunders CA; Liniker E; Ramanujam S; Guminski A; Kefford RF; Long GV; Carlino MS
    Pigment Cell Melanoma Res; 2016 Sep; 29(5):572-7. PubMed ID: 27333363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy.
    Paudyal B; Oriuchi N; Paudyal P; Tsushima Y; Iida Y; Higuchi T; Hanaoka H; Miyakubo M; Takano A; Ishikita T; Endo K
    Oncol Rep; 2007 Dec; 18(6):1469-73. PubMed ID: 17982632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of early 18F-FDG PET to evaluate the effectiveness of radiofrequency ablation of liver metastases.
    Khandani AH; Calvo BF; O'Neil BH; Jorgenson J; Mauro MA
    AJR Am J Roentgenol; 2007 Nov; 189(5):1199-202. PubMed ID: 17954661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla JF; Sainz-Esteban A; Barragán J; Portilla-Quattrociocchi H; Carril JM
    Rev Esp Med Nucl; 2008; 27(3):168-75. PubMed ID: 18570858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography with F-18 fluorodeoxyglucose in evaluating colorectal hepatic metastasis down-staged by chemotherapy.
    Takahashi S; Kuroki Y; Nasu K; Nawano S; Konishi M; Nakagohri T; Gotohda N; Saito N; Kinoshita T
    Anticancer Res; 2006; 26(6C):4705-11. PubMed ID: 17214330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual uptake of 18FDG by a hepatic adenoma.
    Fosse P; Girault S; Hoareau J; Testard A; Couturier O; Morel O
    Clin Nucl Med; 2013 Feb; 38(2):135-6. PubMed ID: 23334131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of 18F-FDG PET scan in the differential diagnosis of large pancreatic masses].
    Tlostanova MS; Tiutin LA; Ryzhkova DV; Pavlovskiĭ AV; Popov SA
    Vopr Onkol; 2008; 54(4):439-44. PubMed ID: 18942397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.
    Paudyal B; Paudyal P; Oriuchi N; Tsushima Y; Nakajima T; Endo K
    Int J Oncol; 2008 Nov; 33(5):1047-54. PubMed ID: 18949368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.